<?xml version="1.0"?>

<document>
	<title>The use and abuse of antibiotics, including in management of
   pulmonary manifestations in cystic fibrosis.</title>

	<author>Kulczycki-L-L.</author>
	<author>Wientzen-R.</author>

	<source>Monogr-Paediatr. 1979. 10. P 27-30.</source>

	<abstract>Individually and collectively opinion is expressed that antibiotics
   are among the most frequently prescribed drugs in United States,
   probably also in many other countries.  While it is adopted by many
   that the increased longevity of cystic fibrosis patients is strongly
   related to antibiotic usage, this has never been documented
   adequately.  The principles which we try to follow while using
   antibiotics in CF patients are outlined.</abstract>

	<majorsubject>ANTIBIOTICS: tu</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: dt</majorsubject>
	<majorsubject>LUNG-DISEASES: dt</majorsubject>

	<minorsubject>ANTIBIOTICS: ad</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: co</minorsubject>
	<minorsubject>SUBSTANCE-ABUSE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>LUNG-DISEASES: et</minorsubject>
	<minorsubject>TOBRAMYCIN: tu</minorsubject>

	<reference>001   ROBERTS AW            AM J HOSP PHARM                 29   828 972</reference>
	<reference>002   SCHECKLER WE          JAMA                           213   264 970</reference>
	<reference>003   ACHONG MR             CAN MED ASSOC J                116   256 977</reference>
	<reference>004   CASTLE M              JAMA                           237  2819 977</reference>
	<reference>005   KUNIN CM              ANN INTERN MED                  79   555 973</reference>
	<reference>006   FINLAND M             J INFECT DIS                   122   419 970</reference>
	<reference>007   MCGOWAN JE JR         J INFECT DIS                   130   165 974</reference>
	<reference>008   OSOL A                UNITED STATES DISPENSATORY               973</reference>
	<reference>009   LARAYA-CUASAY LR      J PEDIATR                       89    23 976</reference>
	<reference>010   DAVIS BD              MICROBIOLOGY                         783 973</reference>
	<reference>011   DI SANTAGNESE PA      AM J DIS CHILD                  72    17 946</reference>
	<reference>012   HUANG NN              J PEDIATR                       59   512 961</reference>
	<reference>013   BURNS MW              LANCET                           1   270 968</reference>
	<reference>014   DOERSHUK CF           IN: MANGOS JA                            976</reference>
	<reference>015   KULCZYCKI LL          JAMA                           240    30 978</reference>


</document>
